Your browser doesn't support javascript.
loading
Seizures in Sotos syndrome: Phenotyping in 49 patients.
Fortin, Olivier; Vincelette, Christian; Khan, Afsheen Q; Berrahmoune, Saoussen; Dassi, Christelle; Karimi, Mitra; Scheffer, Ingrid E; Lu, Jun; Davis, Kellie; Myers, Kenneth A.
Afiliación
  • Fortin O; Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada.
  • Vincelette C; School of Nursing, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada.
  • Khan AQ; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Berrahmoune S; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Dassi C; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Karimi M; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Scheffer IE; Epilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
  • Lu J; Department of Paediatrics, Royal Children's Hospital, The University of Melbourne, Flemington, Victoria, Australia.
  • Davis K; The Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia.
  • Myers KA; Department of Pediatrics, Haikou People's Hospital, Haikou, China.
Epilepsia Open ; 6(2): 425-430, 2021 06.
Article en En | MEDLINE | ID: mdl-34033256
ABSTRACT
We aimed to describe the phenotypic spectrum of seizures in Sotos syndrome, a genetic condition involving overgrowth, macrocephaly, dysmorphic features, and learning disability, in which 60%-90% have NSD1 pathogenic variants. Patients were recruited from clinics and referral from support groups. Those with seizures and a clinical diagnosis of Sotos syndrome were included. Phenotyping data were collected via structured clinical interview and chart review. Forty-nine patients were included. Twenty had NSD1 testing results available; of these, 15 (75%) had NSD1 pathogenic variants. Seizure onset age ranged from 3 months to 12 years. Staring spells (absence or focal impaired awareness seizure) were the most frequently reported semiology (33/49; 67%), followed by febrile seizures (25/49; 51%) and afebrile bilateral tonic-clonic seizures (25/49; 51%). Most patients (33/49; 67%) had multiple seizure types. The majority (33/49; 67%) had seizures controlled on a single antiseizure medication or no medication. Nine (18%) had drug-resistant epilepsy. Epilepsy syndromes included febrile seizures plus, Lennox-Gastaut syndrome, childhood absence epilepsy, and generalized tonic-clonic seizures alone. The seizure phenotype in Sotos syndrome most commonly involves staring spells, afebrile tonic-clonic seizures or febrile convulsions; however, other seizure types may occur. Seizures are typically well-controlled with medication, but drug-resistant epilepsy occurs in a minority.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Epilepsias Parciales / Epilepsia Tipo Ausencia / Convulsiones Febriles / Síndrome de Sotos Tipo de estudio: Qualitative_research Límite: Child / Humans Idioma: En Revista: Epilepsia Open Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Epilepsias Parciales / Epilepsia Tipo Ausencia / Convulsiones Febriles / Síndrome de Sotos Tipo de estudio: Qualitative_research Límite: Child / Humans Idioma: En Revista: Epilepsia Open Año: 2021 Tipo del documento: Article País de afiliación: Canadá